FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to new therapeutic drugs for the treatment of neurodegenerative diseases, their production and use. A compound of formula I is proposed, as well as the use of a compound of formula I for the preparation of a drug for the prevention, alleviation or treatment of neurodegenerative diseases or depression, and a pharmaceutical composition containing the said compound and a pharmaceutically acceptable carrier. Also a method is provided for the prevention, alleviation or treatment of neurodegenerative diseases or depression, comprising administering to a subject in need thereof an effective amount of a compound of formula I or a pharmaceutically acceptable salt thereof, in particular compounds II, III, IV or V. Methods for preparing compounds III, IV or V are also provided. It has been shown that the compound of formula I can effectively enhance the functioning of neural stem cells in both in vivo and in vitro experiments, and can be used as part of a therapeutic approach to accelerate neuroregeneration to combat cognitive decline associated with the aging process or a neurodegenerative disease.
EFFECT: obtaining a therapeutic drug for the treatment of neurodegenerative diseases.
18 cl, 18 dwg, 18 ex
Title | Year | Author | Number |
---|---|---|---|
NEW COMPOSITION FOR TREATMENT OR PREVENTION OF A NEURODEGENERATIVE DISEASE AND ITS USE | 2019 |
|
RU2791317C2 |
PHARMACEUTICAL COMPOSITION FOR INHIBITING NEURONAL APOPTOSIS OR NEURODEGENERATION | 2011 |
|
RU2586772C2 |
ALPHA-AMINOAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREWITH | 2015 |
|
RU2673622C2 |
PHARMACEUTICAL COMPOSITION FOR INHIBITING APOPTOSIS OF NEURONS OR NEURODEGENERATION | 2011 |
|
RU2722018C2 |
N-(2-THIAZOLYL)AMIDE DERIVATIVES AS GSK-3 INHIBITORS | 2007 |
|
RU2450000C2 |
N-(2-THIAZOLYL)AMIDE DERIVATIVES AS GSK-3 INHIBITORS | 2007 |
|
RU2429237C2 |
ANALOGUES OF CYSTAMINE, USED FOR PARKINSON'S DISEASE TREATMENT | 2012 |
|
RU2630583C2 |
DIKETONES AND HYDROXYKETONES AS ACTIVATORS OF CATENIN SIGNALLING PATHWAY | 2011 |
|
RU2592694C2 |
COMPOUNDS FOR TREATMENT OF AMYLOIDOSIS | 2009 |
|
RU2491953C2 |
COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING BETA-AMYLOID DISEASES AND SYNUCLEINOPATHIES | 2009 |
|
RU2501792C2 |
Authors
Dates
2023-07-05—Published
2019-01-29—Filed